The Worldwide Image Guided Radiotherapy Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The World Image Guided Radiotherapy Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2023, outperforming its past development records as far as esteem and volume. The global Image Guided Radiotherapy market is expected to reach US$ 12.3 billion by 2023, and the market is expected to grow at a CAGR of 15.8% during the forecasted period.
Some of the Key Players in the image guided radiotherapy market are ViewRay (US), General Electric Company (US), Hitachi, Ltd. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherland), TOSHIBA CORPORATION (Japan), Varian Medical Systems, Inc. (US), Vision RT Ltd. (UK), Scranton Gillette Communications (US), XinRay Systems (US), and C-RAD (Sweden).
Image guided radiotherapy (IGRT), a type of conformal radiotherapy, involves the use of different scans and X-rays to treat an area of cancer. Conformal radiotherapy shape the radiotherapy beams around the area of the cancerous tissue. It uses X-rays and scans similar to CT scans before and during the radiotherapy treatment. It improves the precision and accuracy of treatment delivery. These therapy are majorly used in the treatment of cancer such as lung cancer, skin cancer, and others.
Increasing prevalence of cancer and rapid development in the cancer treatment drives the growth of the market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality worldwide. The data also suggest that about 14 million new cases observed in 2012, which is expected to increase by 70% till 2030. Apart from this, continuously rising demand for the better cancer treatment, increasing healthcare expenditure, and government encouragement for research & development expected to fuel the growth of the market over the corresponding period.
On the other hand, high cost of the treatment & devices and side effects of the treatment may slow the market growth over the forecasted period
The global image guided radiotherapy market is segmented on the basis of types, technology, devices, application, and end users.
On the basis of types, the market is segmented into soft-tissue imaging, lung MRI, simplifying cardiac MRI, simplifying MRI-conditional implant scans, and silent MRI scanning.
On the basis of technology the market is segmented into radiation-based, non-radiation based systems, and others. Radiation-based system is further segmented into electronic portal imaging devices (EPID), cone beam CT, Fan beam, and others. Non-radiation based systems are further segmented into ultrasound-based systems, camera-based or optical tracking systems, MRI-guided IGRT, and others.
On the basis of devices, the market is segmented into X-ray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography, and others. X-ray computed tomography market is further segmented into digital X-ray, computed tomography (CT), conventional CT, optical tracking, cone beam, MVCT, and others.
On the basis of end users, the market is segmented in hospitals, smart cancer centers, research institutes, and others.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4276 .
The Americas account for the largest share in the global Image Guided Radiotherapy Market owing to the presence of huge patient population and increasing healthcare expenditure. According to the American Cancer Society, in 2016, over 1,688,780 cancer cases were diagnosed in the America. Moreover, increasing awareness among the people and well-developed technology have fuelled the market growth.
Europe is the second largest market and holds a noticeable share in the global image guided radiotherapy market. The European market is expected to grow significantly during the forecast period owing to availability of advanced treatment facilities, skilled medical professionals, and the government support for research & development.
Asia Pacific accounts for the fastest growing market owing to increasing prevalence of cancer, rising awareness about the cancer, and availability of new treatment methods. In Asia Pacific, the market shows growth opportunities in China and India.
However, the Middle East & Africa is expected to show the least growth in this market due to lack of awareness, limited development in healthcare technology, and availability of treatment facilities.
Table of Contents
Chapter 1 Report Prologue
Chapter 2 Market Introduction
Chapter 3 Research Methodology
Chapter 4 Market Dynamics
Chapter 5 Market Factor Analysis
Chapter 6 Global Image Guided Radiotherapy Market, By Types
Chapter 7 Global Image Guided Radiotherapy Market, By Technology
Chapter 8 Global Image Guided Radiotherapy Market, By Devices
Chapter 9 Global Image Guided Radiotherapy Market, By End Users
Chapter 10 Global Image Guided Radiotherapy Market By Region
Chapter 11 Company Landscape
Chapter 12 Company Profiles
Chapter 13 MRFR Conclusion
GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4276 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312